Novo Nordisk As Stock Today
| NONOF Stock | USD 105.00 3.79 3.74% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Novo Nordisk is trading at 105.00 as of the 21st of November 2024. This is a 3.74 percent up since the beginning of the trading day. The stock's lowest day price was 105.0. Novo Nordisk has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Novo Nordisk AS are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of May 2024 and ending today, the 21st of November 2024. Click here to learn more.
Novo Nordisk AS, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. NOVO NORDISK is traded on OTC Exchange in the United States. The company has 1.72 B outstanding shares. More on Novo Nordisk AS
Moving together with Novo Pink Sheet
| 0.99 | NVO | Novo Nordisk AS | PairCorr |
| 0.87 | CSLLY | CSL | PairCorr |
| 0.69 | CMXHF | CSL Limited | PairCorr |
| 0.95 | REGN | Regeneron Pharmaceuticals | PairCorr |
Moving against Novo Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Novo Pink Sheet Highlights
| President | Maziar Doustdar |
| Old Name | Novo Nordisk A/S B |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Novo Nordisk AS [NONOF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Mega-Cap' category with a current market capitalization of 318.05 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Novo Nordisk's market, we take the total number of its shares issued and multiply it by Novo Nordisk's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Novo Nordisk AS classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 1.72 B outstanding shares.
Novo Nordisk AS has accumulated about 31.04 B in cash with 78.89 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.68.
Check Novo Nordisk Probability Of Bankruptcy
Ownership AllocationNovo Nordisk AS maintains a total of 1.72 Billion outstanding shares. 30% of Novo Nordisk outstanding shares are owned by institutional investors. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Novo Ownership Details
Novo Nordisk AS Risk Profiles
| Mean Deviation | 1.99 | |||
| Standard Deviation | 2.51 | |||
| Variance | 6.28 | |||
| Risk Adjusted Performance | (0.10) |
Novo Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Novo Nordisk without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Additional Information and Resources on Investing in Novo Pink Sheet
When determining whether Novo Nordisk AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Novo Nordisk's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Novo Nordisk As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Novo Nordisk As Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novo Nordisk AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.